FDA panel backs Alzheimer's drug that can reportedly slow cognitive decline

The FDA has approved a new medication aimed at slowing the effects of Alzheimer's disease. An advisor claims the drug's benefits outweigh its risks, potentially delaying cognitive decline by several months. However, experts are divided on whether patients or their families will notice a significant difference.

What new insight or understanding did you gain from this video?